Diabetes-Induced Oxidative Stress in Endothelial Progenitor Cells May Be Sustained by a Positive Feedback Loop Involving High Mobility Group Box-1

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Wu, Han ^a   Li, Ran ^a   Wei, Zhong Hai ^a   Zhang, Xin Lin ^a   Chen, Jian Zhou ^a   Dai, Qing ^a   Xie, Jun ^a   Xu, Biao ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CELL CULTURE; CELLS; CYTOLOGY; ENDOTHELIAL CELLS; ENZYMES; HEART VALVE PROSTHESES; MAMMALS; OXIDATIVE STRESS; OXYGEN;

CRITICAL FACTORS; DOSE-DEPENDENT MANNER; ENDOTHELIAL PROGENITOR CELLS; HIGH-MOBILITY GROUPS; N-ACETYLCYSTEINE; OXYGEN SPECIES; POSITIVE FEEDBACK LOOP; SUPEROXIDE DISMUTASE ACTIVITIES;

FEEDBACK;

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; P66SHC PROTEIN; PROTEIN P66; PROTEIN SHC; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; SHC SIGNALING ADAPTOR PROTEIN; SHC TRANSFORMING PROTEIN 1; SHC1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MONOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; IN VITRO STUDY; MALE; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; POSITIVE FEEDBACK; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SERUM; SIGNAL TRANSDUCTION; STEM CELL CULTURE; SUPERNATANT; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; BLOOD; BODY WEIGHT; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY; PHYSIOLOGICAL FEEDBACK;

ACETYLCYSTEINE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BONE MARROW CELLS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL PROGENITOR CELLS; FEEDBACK, PHYSIOLOGICAL; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYCYRRHIZIC ACID; HMGB1 PROTEIN; MALE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MONOCYTES; OXIDATIVE STRESS; SHC SIGNALING ADAPTOR PROTEINS; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; UP-REGULATION;

EID: 84954304927     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/1943918     Document Type: Article

References (34)

1. K.-A. Kim, Y.-J. Shin, J.-H. Kim et al., "Dysfunction of endothelial progenitor cells under diabetic conditions and its underlying mechanisms, " Archives of Pharmacal Research, vol. 35, no. 2, pp. 223-234, 2012.
2. D. Tousoulis, N. Papageorgiou, E. Androulakis et al., "Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches, " Journal of the American College of Cardiology, vol. 62, no. 8, pp. 667-676, 2013.
3. C. Alev, M. Ii, and T. Asahara, "Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases, " Antioxidants and Redox Signaling, vol. 15, no. 4, pp. 949-965, 2011.
4. A. Georgescu, N. Alexandru, A. Constantinescu, I. Titorencu, and D. Popov, "The promise of EPC-based therapies on vascular dysfunction in diabetes, " European Journal of Pharmacology, vol. 669, no. 1-3, pp. 1-6, 2011.
5. C. J. M. Loomans, E. J. P. De Koning, F. J. T. Staal et al., "Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes, " Diabetes, vol. 53, no. 1, pp. 195-199, 2004.
6. N. António, R. Fernandes, A. Soares et al., "Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum, " Cardiovascular Diabetology, vol. 13, no. 1, article 101, 2014.
7. K. Maiese, "New insights for oxidative stress and diabetes mellitus, " Oxidative Medicine and Cellular Longevity, vol. 2015, 17 pages, 2015.
8. C. J. M. Loomans, E. J. P. De Koning, F. J. T. Staal, T. J. Rabelink, and A.-J. Van Zonneveld, "Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?" Antioxidants and Redox Signaling, vol. 7, no. 11-12, pp. 1468-1475, 2005.
9. G. P. Fadini, D. Losordo, and S. Dimmeler, "Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use, " Circulation Research, vol. 110, no. 4, pp. 624-637, 2012.
10. V. L. Bodiga, S. R. Eda, and S. Bodiga, "Advanced glycation end products: role in pathology of diabetic cardiomyopathy, " Heart Failure Reviews, vol. 19, no. 1, pp. 49-63, 2014.
11. M. E. Cooper, "Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease, " American Journal of Hypertension, vol. 17, no. 12, part 2, pp. 31S-38S, 2004.
12. N. M. J. Hanssen, J. W. J. Beulens, S. Van Dieren et al., "Plasma advanced glycation end products are associated with incident cardiovascularevents in individualswith type 2 diabetes: aCase-Cohort study with a median follow-Up of 10 years (EPIC-NL), " Diabetes, vol. 64, no. 1, pp. 257-265, 2015.
13. J. Chen, M. Song, S. Yu et al., "Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress, " Molecular and Cellular Biochemistry, vol. 335, no. 1-2, pp. 137-146, 2010.
14. Q. Chen, L. Dong, L. Wang, L. Kang, and B. Xu, "Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2, " Biochemical and Biophysical Research Communications, vol. 381, no. 2, pp. 192-197, 2009.
15. Y. Yu, D. Tang, and R. Kang, "Oxidative stress-mediated HMGB1 biology, " Frontiers in Physiology, vol. 6, article 93, 2015.
16. C. Zhang, M. Mo, W. Ding et al., "High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca2+ leak through TLR4-ROS signaling in cardiomyocytes, " Journal of Molecular and Cellular Cardiology, vol. 74, pp. 260-273, 2014.
17. S. E. Hermansen, T. Lund, T. Kalstad, K. Ytrehus, and T. Myrmel, "Adrenomedullin augments the angiogenic potential of late outgrowth endothelial progenitor cells, " The American Journal of Physiology-Cell Physiology, vol. 300, no. 4, pp. C783-C791, 2011.
18. A. Yamashita, K. Nishihira, Y. Matsuura et al., "Paucity of CD34-positive cells and increased expression of high-mobility group box 1 in coronary thrombus with type 2 diabetes mellitus, " Atherosclerosis, vol. 224, no. 2, pp. 511-514, 2012.
19. F. Delucchi, R. Berni, C. Frati et al., "Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats, " PLoS ONE, vol. 7, no. 6, Article ID e39836, 2012.
20. J. Skrha, M. Kalousová, J. Svarcová et al., "Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus, " Experimental and Clinical Endocrinology and Diabetes, vol. 120, no. 5, pp. 277-281, 2012.
21. H. Wang, H. Qu, and H. Deng, "Plasma HMGB-1 levels in subjectswith obesity and type 2 diabetes: a cross-sectional study in China, " PLOS ONE, vol. 10, no. 8, Article IDe0136564, 2015.
22. D. Yao and M. Brownlee, "Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands, " Diabetes, vol. 59, no. 1, pp. 249-255, 2010.
23. Y. Wang, J. Shan, W. Yang, H. Zheng, and S. Xue, "High mobility group box 1 (HMGB1) mediates high-glucose-induced calcification in vascular smooth muscle cells of saphenous veins, " Inflammation, vol. 36, no. 6, pp. 1592-1604, 2013.
24. W.-K. Wang, Q.-H. Lu, J.-N. Zhang et al., "HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway, " Journal ofCellular andMolecular Medicine, vol. 18, no. 11, pp. 2311-2320, 2015.
25. N. Maugeri, P. Rovere-Querini, M. Baldini et al., "Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis, " Antioxidants & Redox Signaling, vol. 20, no. 7, pp. 1060-1074, 2014.
26. W. Xu, Y. Lu, J. Yao et al., "Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury, " Shock, vol. 42, no. 5, pp. 440-447, 2014.
27. S. Hamed, B. Brenner, A. Aharon, D. Daoud, and A. Roguin, "Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus, " Cardiovascular Diabetology, vol. 8, article 56, 2009.
28. M. Kalousová and T. Zima, "AGEs and RAGE-advanced glycation end-products and their receptor in questions and answers, " Vnitrni Lekarstvi, vol. 60, no. 9, pp. 720-724, 2014.
29. J. Chen, L. Huang, M. Song, S. Yu, P. Gao, and J. Jing, "Creactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells, " Journal of Cardiovascular Pharmacology, vol. 53, no. 5, pp. 359-367, 2009.
30. L. Feng, M. Zhu, M. Zhang et al., "Amelioration of compound 4, 4-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-B pathway, " International Immunopharmacology, vol. 15, no. 2, pp. 206-216, 2013.
31. A. Vikram, Y.-R. Kim, S. Kumar et al., "CanonicalWnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 10, pp. 2301-2309, 2014.
32. S. Zhou, H.-Z. Chen, Y.-Z. Wan et al., "Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction, " Circulation Research, vol. 109, no. 6, pp. 639-648, 2011.
33. V. Di Stefano, C. Cencioni, G. Zaccagnini, A. Magenta, M. C. Capogrossi, and F. Martelli, "P66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose, " Cardiovascular Research, vol. 82, no. 3, pp. 421-429, 2009.
34. H. Li, X. Zhang, X. Guan et al., "Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells, " Cardiovascular Diabetology, vol. 11, article 46, 2012.